About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Targeted Therapies Help Decrease Lung Fibrosis

by Angela Mohan on November 11, 2020 at 11:48 AM
Font : A-A+

New Targeted Therapies Help Decrease Lung Fibrosis

Idiopathic pulmonary fibrosis (IPF) patients, who have a life expectancy of less than five years, could benefit from new targeted drug therapies.

Philip S. Low, the Purdue Ralph C. Corley, Professor of Chemistry and Presidential Scholar for Drug Discovery, has led a team to develop two targeted therapies for IPF patients. The details are published in Science Translational Medicine and EMBO Molecular Medicine.

Advertisement


"This is a horrible disease that claimed the lives of my next-door neighbor and a good friend's wife," Low said. "We developed two targeted therapies that allow us to use powerful drugs with high toxicities because we specifically deliver them to diseased cells without harming healthy ones."

The first therapy is designed to slow fibrosis and improve survival rate. The second one is to suppresses fibrosis-inducing cytokine production.

These therapies will be moving into human clinical trials soon, as many patients with COVID-19 or who have recovered from COVID-19 experience lung fibrosis or related conditions.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Tea Protects against Blood Pressure and Heart Diseases
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
Cervical Cancer Awareness Month 2022
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pneumoconiosis Silicosis Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

Recommended Reading
Pulmonary Fibrosis
Do you find yourself out of breath and coughing a lot lately? Do you work in dust prone places? ......
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to e...
Pneumoconiosis
Pneumoconiosis is a group of lung diseases caused by inhaled dust particles. It causes inflammation ...
Retroperitoneal Fibrosis / Ormondīs Disease
Retroperitoneal fibrosis or Ormond's disease a rare disorder occurs when extra fibrous tissue forms ...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)